FOXO4-DRI Peptide – Research Peptide for Cellular Rejuvenation & Repair

FOXO4-DRI is a synthetic peptide being studied for its potential role in regulating cellular aging and repair processes. It targets senescent (aged) cells and is being investigated as a potential key to regeneration, anti-aging, and cell renewal studies. Developed from the natural FOXO4 protein, FOXO4-DRI offers scientists insights into the mechanisms of cell rejuvenation and tissue repair.

Benefits of FOXO4-DRI

• Studied for its role in cell renewal and regeneration
• Linked in studies to anti-aging and tissue repair
• Interesting for mitochondrial health research
• High purity and controlled laboratory quality
• Buying FOXO4-DRI may be valuable for research projects on aging

How does FOXO4-DRI work?

In laboratory research, FOXO4-DRI targets the interaction between the FOXO4 protein and the p53 signaling pathway—a key mechanism involved in cell survival and aging. By modulating this interaction, the peptide can help study the elimination of senescent cells, providing insights into natural rejuvenation processes. This makes it relevant for research on tissue regeneration, cell stress, and metabolic health.

Preparation and storage

FOXO4-DRI is supplied as a freeze-dried (lyophilized) powder. For research use, it must be reconstituted with bacteriostatic water.
Storage: between 2°C and 8°C in a dry, dark environment to maintain stability and efficacy.

Purity and quality

Each batch of FOXO4-DRI is analytically verified with a COA (Certificate of Analysis) confirming purity, identity, and stability. Purity is ≥99%, as tested by HPLC and mass spectrometry. This guarantees reliable results in cell and molecular studies.

Legal disclaimer

FOXO4-DRI is intended for scientific research and laboratory use only. Not intended for human consumption, medical use, or cosmetic purposes.

Want to know more?

Read our comprehensive blog on FOXO4-DRI and discover the latest research insights into cell rejuvenation, senescence, and regenerative biology.